Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
david b stocker...sounds like an honest chap?
http://www.google.com/#sclient=psy-ab&hl=en&safe=off&site=&source=hp&q=david+b+stocker&psj=1&oq=david+b+stocker&aq=f&aqi=g10&aql=&gs_sm=e&gs_upl=1373l4976l0l5179l15l4l0l0l0l0l1420l2699l4-1.0.1.1l3l0&bav=on.2,or.r_gc.r_pw.,cf.osb&fp=6ec2ef983cfe5559&biw=1024&bih=395
Can cross Chaim Stern off the name of people to trust on this one, seemed a bit sketchy after I dug a few days on it last June. Any word on why the suspension? Seems like it's been barely traded much in last six months.
wow SUSPENDED, I hope the SEC finds and prosecutes the promoters of this trash stock
amelow, we're still working through the DD here and trying to unravel what is going on here. I recommend you taking a look at the last couple days of DD, that is what we know so far. Not a ton yet and nothing for sure. Always looking for more people to research, if you want add anything, please feel free.
what's going on here
seems to be similar story to that on EUOT board with talk of reverse merger? other than a couple of trades, what does anyone have on it? thanks
Yes, this one is on radar
Intersting action here today
1. Subscription. Subject to the terms and conditions hereof, CHAIM AND MARGARET STERN, the undersigned Investor ("Investor") hereby subscribes to purchase (i) Two Million Five Hundred Thousand (2,500,000) Shares of Bio-Life Labs, Inc. , at a purchase price of $0.04 per Share
Chaim Stern's relationship with BCLE began in 2005 as a shareholder.
http://msnmoney.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTML1?ID=3783513&SessionID=1_RjWMJpzzfnEu9
Looks like he also had some holdings in Applied DNA Sciences as well, although he may have totally sold out now. The one thing I get from that is it tells us this guy plays biotechs. Cobalis, Applied DNA Sciences and now runs BLFE shell. I'm going to look and see if there any assets he might have gotten with the shell.
http://www.sec.gov/Archives/edgar/data/744452/000118811209000339/t64592_posam.htm
nice, at least that confirms he has his hands in other plays, want to dig through some of those CLSC filings, see if they can get us any more info. See how well connected and if he has any other plans here.
Looks like a nice place. Interesting reading on the CLSC board regarding Mr. Stern.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=4807&srchyr=2010&SearchStr=stern
I actually know that area of Brooklyn pretty well, live down there part-time not too far from many of those streets.
I just found this regarding Chaim Stern, I'm sure there is more, but for now here is a Form 3 that he filed with Cobalis Corp, ticker CLSC.
http://msnmoney.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTML1?ID=6905613&SessionID=GKeKWZn2t35_P49
Did you notice that 2 out of the 5 names on that list are Chaim and another is Chaimovitz? I've never heard the name Caim before and according to this, there are 2-3 on this block alone.
I agree, will check and see what I can find as well, the more eyes the better....
Thank you again for that find :)
I suspect things could start to heat up here beginning tomorrow toucan. I just hope we can find some more info on what is going on behind the scenes.
I've never seen it actually. In fact, even though I suspected it wasn't his name, I wasn't sure because I've never run across it before. Interesting though. Hope we can dig up some more info on this one. The price for entry is certainly right IMO with a current market cap of around $25000.
Great find prado,
thank you :)
Looks like he is the shell owner, or owner of assets. Strange that he used the word custodian however, rarely ever seen that in Nevada SOS filings, have you?
Great find level. I'm going to see if I can find some more info on him.
Based on address, looks like his name is Chaim Stern, named custodian to this account. Unusual the use of the word custodian, peeks my interest.
http://brooklyn.blockshopper.com/zips/11210/streets/e.27th.st/order_by/owner/asc
06/15/10 Annual list on NV SOS lists a Custodian C Stern as the all the directors directors.
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=TJMWEFpd42poinQx0DbL%252fw%253d%253d
Need to do some dd
Meuse Shell
Remember Stocker has a big stake in the succss of this shell as his Co owned 57% of the OS, which redueces the probability of an RS tremendously!!
Stocker resigned 2 months ago,
Last month an RA change,
THIS MONTH ???? RM ANNOUNCMENT?????
Sure hate to chase them when the news hits!!
I held this one a LONG time ago - used to be one of my favorites. Will keep on watch.
Another bit of interesting info, Stockers Co (Carrera Capitol CCI) holds 57% of the OS, per SC13D from 5-2007!!
Just filed Resignation of Officers and Resident agent Change, good sign that the shell has sold or a merger is pending!!
Actions\Amendments
Action Type: Resident Agent Name Change
Document Number: 20080155728-48 # of Pages: 32
File Date: 03/03/2008 Effective Date:
(No notes for this action)
Action Type: Resignation of Officers
Document Number: 20080100264-83 # of Pages: 1
File Date: 02/11/2008
https://esos.state.nv.us/SOSServices/AnonymousAccess/CorpSearch/corpActions.aspx?lx8nvq=C1V4KthpIw05NzQQnppc6g%253d%253d&CorpName=BIO-LIFE+LABS%2c+INC.
Well someone is watching. Darn thing is up 233% Today. ???
Spring, a great time for reverse mergers.
Looks like BLFE will lay dormant till a reverse merger.
Wonder what ever happened to the Doctors that developed carcinaderm. Looked real promising.
rm coming?
BLFE
Resident Agent Change
Document Number: 20070828010-28 # of Pages: 1
File Date: 12/03/2007
https://esos.state.nv.us/SOSServices/AnonymousAccess/CorpSearch/corpActions.aspx?lx8nvq=C1V4KthpIw05NzQQnppc6g%253d%253d&CorpName=BIO-LIFE+LABS%2c+INC.
Resident Agent Information
Name: SANTORO, DRIGGS, WALCH, KEARNEY, HOLLEY & THOMPSON Address 1: 400 SOUTH FOURTH STREET
Address 2: THIRD FLOOR City: LAS VEGAS
State: NV Zip Code: 89101
http://www.santorodriggs.com/
Form 13D Filing points of interest:
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
On July 18, 2006, Carrera Capital, Inc., a Texas corporation owned and controlled by David B. Stocker, agreed to contribute a minimum of twenty-five thousand dollars ($25,000.00) as paid in capital to the Company to pay for reinstating the Company with the state of Nevada and past due franchise taxes, reinstating the Company and bringing it into good standing with its transfer agent, current accounting, and filings with the Securities and Exchange Commission, so as to reactivate the Company as a reporting company. Carrera Capital has also agreed to advise the Company as to potential business combinations. In consideration for the $25,000.00 contribution, the agreement to contribute such additional funds as are necessary to accomplish the foregoing, and for services, the Company issued 100,000,000 shares of its common stock to Carrera Capital. All funds are the personal funds of David B. Stocker and Carrera Capital.
ITEM 4. PURPOSE OF TRANSACTION.
The purpose of the transaction was to obtain the necessary capital contribution in order to pay for reinstating the Company with the state of Nevada and past due franchise taxes, reinstating the Company and bringing it into good standing with its transfer agent, current accounting, and filings with the Securities and Exchange Commission, so as to reactivate the Company as a reporting company. In addition, the Company requires ongoing consulting and advisory services to assist in the completion and filing of the delinquent reports in order to bring the Company compliant with the Securities Act of 1934. Moreover, the Company requires the ongoing services of a committed and interested individual and entity to assist the Company with locating a viable merger partner and properly consummating the transaction once the Company is current and compliant. Accordingly, in addition to obtaining a capital contribution, the purpose of the transaction, was to obtain the current and ongoing services of David B. Stocker and Carrera Capital.
Mr. Stocker does not have any present plans or proposals that relate to or would result in the occurrence of any of the events or matters described in Item 4(a)-(j) of Schedule 13D. However, upon ensuring that the Company is current and compliant in its reporting obligations under the Securities Exchange Act of 1934, Mr. Stocker shall seek a merger or acquisition partner that could result in a transaction under Item 4(b) of Schedule 13D.
BLFE Form 13D Filed By David Stocker
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
BIO-LIFE LABS, INC.
(Name of Issuer)
COMMON STOCK, $0.001 PAR VALUE
(Title of Class of Securities)
09059S 10 9
(CUSIP Number)
David B. Stocker, President
2425 East Camelback Road, Suite 1075
Phoenix, AZ 85016
(602) 852-5445
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
July 18, 2006
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-1(a) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
David B. Stocker
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)
PF
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings is Required Pursuant to items 2(d) or 2(e)
[ ]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization
United States
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power
Shares 100,005,000
Beneficially ____________________________________________________________________________________________
Owned by 8. Shared Voting Power
Each 0
Reporting ____________________________________________________________________________________________
Person 9. Sole Dispositive Power
With 100,005,000
____________________________________________________________________________________________
10. Shared Dispositive Power
0
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
100,005,000
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
[ ]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
57%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
IN
2
--------------------------------------------------------------------------------
ITEM 1. SECURITY AND ISSUER.
This statement on Schedule 13D relates to the common stock, $0.001 par value per share ("Common Stock"), of Bio-Life Labs, Inc., a Nevada corporation (the "Company"). The address of the Company's principal executive offices is c/o 2425 East Camelback Road, Suite 10745, Phoenix, Arizona 85016.
ITEM 2. IDENTITY AND BACKGROUND.
(a) David B. Stocker
(b) Business Address: 2425 East Camelback Road, Suite 1075, Phoenix, Arizona 85016.
(c) Consultant, attorney, and current president of Issuer
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: United States
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
On July 18, 2006, Carrera Capital, Inc., a Texas corporation owned and controlled by David B. Stocker, agreed to contribute a minimum of twenty-five thousand dollars ($25,000.00) as paid in capital to the Company to pay for reinstating the Company with the state of Nevada and past due franchise taxes, reinstating the Company and bringing it into good standing with its transfer agent, current accounting, and filings with the Securities and Exchange Commission, so as to reactivate the Company as a reporting company. Carrera Capital has also agreed to advise the Company as to potential business combinations. In consideration for the $25,000.00 contribution, the agreement to contribute such additional funds as are necessary to accomplish the foregoing, and for services, the Company issued 100,000,000 shares of its common stock to Carrera Capital. All funds are the personal funds of David B. Stocker and Carrera Capital.
ITEM 4. PURPOSE OF TRANSACTION.
The purpose of the transaction was to obtain the necessary capital contribution in order to pay for reinstating the Company with the state of Nevada and past due franchise taxes, reinstating the Company and bringing it into good standing with its transfer agent, current accounting, and filings with the Securities and Exchange Commission, so as to reactivate the Company as a reporting company. In addition, the Company requires ongoing consulting and advisory services to assist in the completion and filing of the delinquent reports in order to bring the Company compliant with the Securities Act of 1934. Moreover, the Company requires the ongoing services of a committed and interested individual and entity to assist the Company with locating a viable merger partner and properly consummating the transaction once the Company is current and compliant. Accordingly, in addition to obtaining a capital contribution, the purpose of the transaction, was to obtain the current and ongoing services of David B. Stocker and Carrera Capital.
3
--------------------------------------------------------------------------------
Mr. Stocker does not have any present plans or proposals that relate to or would result in the occurrence of any of the events or matters described in Item 4(a)-(j) of Schedule 13D. However, upon ensuring that the Company is current and compliant in its reporting obligations under the Securities Exchange Act of 1934, Mr. Stocker shall seek a merger or acquisition partner that could result in a transaction under Item 4(b) of Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) Mr. Stocker is deemed the beneficial owner of 100,005,000 shares of Common Stock of the Company representing 57% of the Common Stock of the Company outstanding as of May 25, 2007. This number includes: (i) 100,000,000 shares of Common Stock currently owned by Carrera Capital, Inc., a company owned and controlled by David B. Stocker, (ii) 5,000 shares of Common Stock purchased by Mr. Stocker personally on April 21, 2006 in a market transaction, and (iii) no options.
(b) Mr. Stocker has sole voting power over 100,005,000 shares of the Common Stock and shared voting power over 0 shares of the Common Stock. He has sole dispositive power over 100,005,000 shares of the Common Stock and shared dispositive power over 0 shares of the Common Stock.
(c) Mr. Stocker has not effected any transactions in the Common Stock during the past 60 days.
(d) No other person has the right to receive and the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities owned by Mr. Stocker.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.
The information set forth under Items 3, 4 and 5 and the agreement referred to herein is incorporated herein by reference. As described in Item 3 above, pursuant to an agreement for a capital contribution in the minimum amount of $25,000.00, and for services rendered and to be rendered, Mr. Stocker received 100,000,000 shares of common stock.
Mr. Stocker holds no options to purchase shares of Common Stock pursuant to any stock option or incentive plans and, other than as set forth herein, has no interest in any securities of the Company. There is no agreement to issue Mr. Stocker additional securities of the Company.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
4
--------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: May 25, 2007
By: /s/ David B. Stocker
Name/Title: David B. Stocker
Stocker Shell BLFE 5/24 5pm filing
http://www.secinfo.com/d1aH7u.u1q.htm
thanks joenatural
With newly issued shares representing 57% of the O/S before the issuance, the current O/S count is 276 million and the market cap is now $2.76 million. Not nearly as attractive as an older shell because there's still debts to settle here unlike an older shell where the statute of limitations has already expired and there are no debts unless judgments come into play.
New out at about 1:30 friday and make that 5/11 not 4/11
Keep an eye here... David B. Stocker has been appointed sole director and officer of the registrant.
New out at about 1:30 friday 4/11/07
the e is there.
i hope it goes to .07.
ill pick up some.
fda and finances will come hopefuly.
good luck
If they don't file
The pps could drop back to pre rally levels .07
The company has not givin the public a clue as to what
is going on for some time.
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
403
|
Created
|
09/02/04
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |